1 / 35

COST

COST. European CO operation in the Field of S cientific and T echnical Research. What is COST ?. Intergovernmental co-operation 1971 17 Scientific & Technical domains Participation 34 COST Member States + 1 Co-operating Country (Israel)

pink
Download Presentation

COST

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. COST European COoperation in the Field of Scientific and Technical Research

  2. What is COST ? • Intergovernmental co-operation • 1971 • 17 Scientific & Technical domains • Participation • 34 COST Member States + 1 Co-operating Country (Israel) • International organisations and research establishments from non-COST countries • The European Commission • COST Actions • Concerted Actions (Networks) of nationally funded R&D

  3. Advantages of COST • Fosters S&T Co-operation across Europe by creating lasting networks of scientists & researchers • Promotes co-operation between Candidate Countries and the EU (particularly the FP) and facilitates their integration • Explores new areas of co-operative research endeavour

  4. COST Countries COST Member States The 25 EU Member States1 • EFTA Member StatesIcelandNorwaySwitzerlandCandidate CountriesBulgariaRomaniaTurkey Other CountriesSerbia and Montenegro2Croatia2FYR of Macedonia (FYROM)2 COST Co-operating StatesIsrael 1from 1 May 04 2Not Associated to FP

  5. European COoperation in the field of Scientific and Technical research REFORM and RENEWAL

  6. Co-ordination through networking Pan-European Multi-disciplinary “Non-competitive” (pre-normative; public utility) National financing of researchers and projects – national responsibility Bottom-up - no fixed programme “A la carte” participation – join in if you are interested “Interdisciplinary Exploratoria” Enabling agent: focus on young scientists Open to wider cooperation Commission involvement COST Characteristics

  7. What is a COST Action? MC = Management Committee CouncilCOST Secretariat COST National Coordinators COMMITTEE OF SENIOR OFFICIALS (CSO) COST OFFICE 9 COST Domain Committees (from 01/06/2006) …….. ……. …… ….. BMBS MC COST Actions (~200) Action WGs WORKING GROUPS (NETWORKS) …… ~30.000 researchers Scientific Domain

  8. COST Actions – what activities? Science management meetings Scientific workshops and seminars Short Term Scientific Missions (STSMs) Training Schools and Research Conferences Dissemination Nationally funded projects (min. 5 signatories) with a joint work programme are receive finance for:

  9. COST Actions – Running Actions 1980-2005 (status 30/11/2005)

  10. COST reforms its governance and structure The COST CSO took two major decisions to advance the reform process of COST during its 163rd meeting 23-24 November 2005. These changes help COST playing its distinct role within the ERA and enhancing its contribution to the Lisbon process.

  11. COST reforms its governance and structure (1) • The scientific and technical Domains in COST are completely restructured. • 9 Domain Committees instead of former 12 Technical Committees supply the CSO with strategic advice. • The nomination procedure for the Domain committee members is under way. The new committee structure will be in place 1 June 2006. KICK-OFF BMBS MEETING programmed on 19 May 2006 in Brussels. All Domain Committees: 15 – 19 May 2006

  12. COST reforms its governance and structure (2) • A majority voting procedure has been adopted for CSO decisions. Instead of making decisions by consensus only, now a simple majority of ¾ of the COST Member States decides. • This will have a significant impact on the COST governance.

  13. COST reforms its governance and structure (3) • An Open Call system was launched on 3 April 2006. • This will improve transparency, secure quality and introduce an element of competitiveness to the selection of COST Actions.

  14. COST governance

  15. COST Scientific and Technical Domains These are the new Domains, as from 1 June 2006. • Biomedicine and Molecular Biosciences • Food and Agriculture • Forests, their Products and Services • Materials, Physical & Nanosciences • Chemistry and Molecular Sciences & Technologies • Earth System Science & Environmental Management • Information & Communication Technologies • Transport & Urban Development • Individuals, Society, Culture & Health

  16. Next steps ”Open Call“: • COST proposed to publish an “Open Call” 3 April 2006 • selection criteria are published and transparent • emphasis will be on young researchers to foster their joint efforts to become better known and recognised • there are specific collection dates (i.e. 31 May2006) • 2 stage process / peer reviewed • first Actions following the “Open Call” to start early 2007

  17. Dedicated instrument proposed “Young Investigators Networks” (YIN): • Exclusively for young scientists at postdoc level, (PhD + max. 5 years); min. 8 young scientists with international experience from 5 COST member states, holding their first position • Eligible activities: meetings, Short Term Scientific Missions, seminars, conferences, outreach activities, plus:[centrally organised & funded] special “YIN Conferences” and research management training • Support: 90 k € p.a. (2006 prices) as annual grant for up to 4 years • Pilot Call for YINs expected in summer 2006 to test the demand

  18. 2006 2007 01 02 03 04 05 06 07 08 09 10 11 12 01 02 03 04 05 06 DC Nominations 2ndcollection date 1st collection date New Domain Actions 2 stage evaluation process CSO decision Open Call CSO CSO CSO CSO CSO CSO decision YIN test call Next steps – tentative timetable DCs operational first YINs starting 2 stage evaluation process Old Domain Actions FP7 FP6 contract

  19. COST Office

  20. Contact: Dr.-Ing. Martin Grabert Director COST Office Av. Louise 149 B 1050 Brussels mgrabert@cost.esf.org cost.esf.org

  21. EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY NEW DOMAIN: BIOMEDICINE AND MOLECULAR BIOSCIENCES (BMBS)

  22. BIOMEDICINE AND MOLECULAR BIOSCIENCES (BMBS)* Definitions* Targets* Thematic scope

  23. Biomedicine:covers all areas of medicine as practiced in Europe: basic, preclinical and clinical medical research* “bench to bedside “ concept.*Acquisition of knowledge of normal functions of the human body and of alterations of these functions in the case of diseases. *Projects conducted at molecular and the whole body level, its integration in the environment included.

  24. Molecular biosciences:all areas of genomics, proteomics and metabolomics. They are not limited to research in humans, but may also concern research in plants, molds, viruses, micro-organisms and animals. Basic and applied biomolecular research is addressed, issues connected with forestry and agriculture included.

  25. Biotechnologies:devoted mainly to pharmacological purposes but this domain will keep some overview function on biotechnological issues specific to other COST domains.

  26. BIOMEDICINE AND MOLECULAR BIOSCIENCES (BMBS)* Definitions* Targets* Thematic scope

  27. *Promote specific COST activities in all medical domains based on the “bench to bedside” concept. *Approach all areas of molecular biosciences in direct connection with the evolution of medical field, of the advanced diagnosis and treatment techniques (technologies and equipment included), of micro- and nano-medicine, etc.

  28. Crucial interdisciplinary areas: *Molecular medicine, molecular and cellular biology *Functional genomics, systems biology *Biotechnology, bioinformatics *Pharmacology *Neurobiology *Medical physics and chemistry*Epidemiology

  29. *Promote Actions with a high degree of innovation, complexity and multidisciplinarity.*Promote Actions which are complementary with respect to the EC Framework Programmes areas.

  30. BIOMEDICINE AND MOLECULAR BIOSCIENCES (BMBS)* Definitions* Targets* Thematic scope

  31. *Genome(s) (cellular and embryonic development, relationship with specific diseases)* Proteins (structures and functions)* Micro- and Nanomedicine* Study of the central nervous system and neuronal connections.

  32. *Immune system, cell migration, cell dysfunctions (cancer)*Cellular mechanisms of metabolic diseases, vascular diseases, diabetes, obesity*Contagious diseases (viruses, micro-organisms, hosts)*Advanced imaging and treatment techniques (basic research, diagnosis, treatment procedures)

  33. *Inter- and multi-disciplinary research within the BMBS and with other COST domains, such as: CMST, MATNANO, ICT, F&A, ISCH, FPS.*Biomedicine, molecular bioscience and pharmacology in extreme conditions, outer space and climate change conditions included.

  34. *Medical devices and new medicines (including nanothechnologies).*Advanced medical research on biomaterials. *Mathematical models in medicine.* Animals – humans transmissible diseases: transmission mechanisms and specific treatment

  35. COST Office • Adress: 149, avenue Louise B-1050 Bruxelles, Belgique • Tél.: +32-2-533 38 00 • Fax: +32-2-533 38 90 • Mel: office@cost.esf.org • BMBS: mpascu@cost.esf.org • WEB:http://www.cost.esf.org

More Related